Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H18N2O2.ClH |
| Molecular Weight | 282.766 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)NCC(O)C1=C2C=CC=NC2=C(O)C=C1
InChI
InChIKey=ZXJJXRFJIDRFPY-UHFFFAOYSA-N
InChI=1S/C14H18N2O2.ClH/c1-9(2)16-8-13(18)10-5-6-12(17)14-11(10)4-3-7-15-14;/h3-7,9,13,16-18H,8H2,1-2H3;1H
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4883832
0.4 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28418-28-2
Created by
admin on Mon Mar 31 23:11:09 GMT 2025 , Edited by admin on Mon Mar 31 23:11:09 GMT 2025
|
PRIMARY | |||
|
NIP1906P54
Created by
admin on Mon Mar 31 23:11:09 GMT 2025 , Edited by admin on Mon Mar 31 23:11:09 GMT 2025
|
PRIMARY | |||
|
355081
Created by
admin on Mon Mar 31 23:11:09 GMT 2025 , Edited by admin on Mon Mar 31 23:11:09 GMT 2025
|
PRIMARY | |||
|
5458816
Created by
admin on Mon Mar 31 23:11:09 GMT 2025 , Edited by admin on Mon Mar 31 23:11:09 GMT 2025
|
PRIMARY | |||
|
31613-92-0
Created by
admin on Mon Mar 31 23:11:09 GMT 2025 , Edited by admin on Mon Mar 31 23:11:09 GMT 2025
|
SUPERSEDED |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD